These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 5886998)

  • 1. [Control of galactose test by short wave treatment of the liver].
    Lindemann A; Teichmann W
    Dtsch Gesundheitsw; 1965 Nov; 20(45):2024-7. PubMed ID: 5886998
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of therapeutic diathermy, paraffin and heat in chronic hepatitis].
    Fidurov IaN
    Vopr Kurortol Fizioter Lech Fiz Kult; 1965; 30(4):318-21. PubMed ID: 5871736
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ultra-high frequency in the combined treatment of Botkin's disease].
    Polonetskaia BN
    Vopr Kurortol Fizioter Lech Fiz Kult; 1965; 30(4):315-8. PubMed ID: 5871735
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of several physical factors in the treatment of patients with residual manifestations of Botkin's disease].
    Katsenovich RA; Tashpulatova NIu
    Vopr Kurortol Fizioter Lech Fiz Kult; 1972; 37(3):232-5. PubMed ID: 5048110
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the use of inductothermia in the complex therapy of children in Botkin's disease].
    Nadtochiĭ AS
    Vopr Okhr Materin Det; 1966 Apr; 11(4):17-21. PubMed ID: 5990943
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver lectin blocking with D-galactose to prevent hepatic metastases in colorectal carcinoma patients.
    Isenberg J; Stoffel B; Stützer H; Otte K; Beuth J
    Anticancer Res; 1997; 17(5B):3767-72. PubMed ID: 9427777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An intravenous galactose tolerance test with an enzymatic determination of galactose. A comparison with other diagnostic aids in hepatobiliary diseases.
    Tengström B
    Scand J Clin Lab Invest Suppl; 1966; 18():132-42. PubMed ID: 5958513
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of hepatic metastases by liver lectin blocking with D-galactose in stomach cancer patients. A prospectively randomized clinical trial.
    Kosik J; Gil J; Szmigielski S; Beuth J; Pulverer G
    Anticancer Res; 1997; 17(2B):1411-5. PubMed ID: 9137507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of hepatic metastases by liver lectin blocking with D-galactose in colon cancer patients. A prospectively randomized clinical trial.
    Warczynski P; Gil J; Szmigielski S; Beuth J; Pulverer G
    Anticancer Res; 1997; 17(2B):1223-6. PubMed ID: 9137476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinico-statistical evaluation of the simultaneous clearance of sulfobromophthalein and galactose in chronic liver diseases].
    Rossi L; Innocenti P; Milani A; Bombardieri G
    Quad Sclavo Diagn; 1983 Jun; 19(2):271-84. PubMed ID: 6676775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [1-(13)C] breath test of galactose and fructose for quantitative liver function.
    Suzuki S; Ishii Y; Asai S; Kohno T; Mazaki T; Takahashi Y; Iwai S; Ishikawa K
    J Surg Res; 2001 Mar; 96(1):90-5. PubMed ID: 11181001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic of posthepatitic liver impairment (post-treatment-results after infectious hepatitis during childhood).
    Ströder J; Haupt H
    Ann Paediatr; 1965; 205(2):105-11. PubMed ID: 5898598
    [No Abstract]   [Full Text] [Related]  

  • 13. 13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis.
    Holtmeier J; Leuschner M; Schneider A; Leuschner U; Caspary WF; Braden B
    Scand J Gastroenterol; 2006 Nov; 41(11):1336-41. PubMed ID: 17060128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The galactose breath test. Modification of the method and comparison with galactose elimination capacity and plasma disappearance of bromsulphatein (author's transl)].
    Grimm L; Bircher J; Preisig R
    Z Gastroenterol; 1980 Jan; 18(1):45-56. PubMed ID: 7385933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravenous loading with galactose as a liver function test. Methods and clinical value].
    Kuntz HD; Kuntz E
    Fortschr Med; 1983 Jun; 101(21):999-1004. PubMed ID: 6873856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactose treatment of multiple sclerosis; a preliminary report.
    HARTSTEIN J; ULETT GA
    Dis Nerv Syst; 1957 Jul; 18(7 Part 1):255-8. PubMed ID: 13447785
    [No Abstract]   [Full Text] [Related]  

  • 17. The future of hepatology.
    Sherlock S
    Neth J Med; 1984; 27(7):262-7. PubMed ID: 6436717
    [No Abstract]   [Full Text] [Related]  

  • 18. [Does serum HCV-RNA-positive hepatitis C differ from serum HCV-RNA-negative hepatitis C?].
    Dällenbach A; Renner EL; Solioz M; Bianchi L; Schmid M; Reichen J
    Schweiz Med Wochenschr; 1995 Oct; 125(40):1855-63. PubMed ID: 7481644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Short-wave therapy as a complementary treatment for chronic prostatitis].
    Zanetić F; Marković B; Starcević L
    Med Arh; 1981; 35(3):157-9. PubMed ID: 7334849
    [No Abstract]   [Full Text] [Related]  

  • 20. [Vascular reactions (according to plethysmographic data) to absolute and conditional irritants in connection with short wave diathermy treatment of patients with hypertensive disease].
    KOSTIUKHINA NA
    Sov Med; 1955 Mar; 19(3):54-61. PubMed ID: 14386093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.